To evaluate the significance of UCA1 in AML, we evaluated its expression in a public gene expression profiling by array from a cohort of cytogenetically normal AML patients containing 16 AML cases with biallelic CEBPA mutations (CEBPAdm) and 130 AML cases with wild type CEBPA [30]. This evidence concerns the gene UCA1 and acute myeloid leukemia.